This site is intended for healthcare professionals only
LoginRegister
Natco Pharma Gets USFDA Tentative Approval for Cancer Drug ErdafitinibNatco Pharma posts Rs 715.3 crore of Profit after tax for year ended March 31st, 2023
Sun Pharma Told to Revise Delafloxacin Phase III Trial ProtocolSun Pharma, Philogen collaborate to commercialise anti-cancer biopharmaceutical Nidlegy in Europe,...
Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspectionJubilant Pharmova arm gets OAI status from USFDA for Montreal facility
Novartis opens new radioligand therapy manufacturing facility in CaliforniaNovartis gets CDSCO panel nod to study anticancer drug Asciminib
Rocky Road to E-Pharmacy RegulationsRocky Road to E-Pharmacy Regulations
Sun Pharma appoints new Whole-time Director, Independent DirectorSun Pharma appoints new Whole-time Director, Independent Director
Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in ChileAurobindo Pharma to sell shares in Auro Vaccines to Curateq Biologics
Novo Nordisk gets EMA panel recommendation for once weekly Sogroya for expanded use in children, adolescents with growth hormone deficiencyNovo Nordisk gets EMA panel recommendation for once weekly Sogroya for expanded use in children,...
Sun Pharma Sees LIC Cross 5% Holding ThresholdSun Pharma proposes to fully acquire Taro Pharmaceutical Industries
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb receives EMA panel recommendation for approval of Opdivo with chemotherapy for...
Akums Drugs & Pharma opens new facilityAkum Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug
Ajanta Pharma Sets Up Wholly Owned Subsidiary in IrelandAjanta Pharma gets CDSCO Panel Nod to manufacture, market high blood pressure FDC drug
X